The global market for Companion Diagnostic was valued at US$ 12640 million in the year 2024 and is projected to reach a revised size of US$ 45200 million by 2031, growing at a CAGR of 20.3% during the forecast period.

Companion Diagnostic Market

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic.

The Companion Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Companion Diagnostic Market Report

Report Metric	Details
Report Name	Companion Diagnostic Market
Accounted market size in year	US$ 12640 million
Forecasted market size in 2031	US$ 45200 million
CAGR	20.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immunohistochemistry Molecular Diagnosis
Segment by Application	Oncology Cardiovascular Central Nervous System Virology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Diagnostic Market growing?

Ans: The Companion Diagnostic Market witnessing a CAGR of 20.3% during the forecast period 2025-2031.

What is the Companion Diagnostic Market size in 2031?

Ans: The Companion Diagnostic Market size in 2031 will be US$ 45200 million.

Who are the main players in the Companion Diagnostic Market report?

Ans: The main players in the Companion Diagnostic Market are Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc

What are the Application segmentation covered in the Companion Diagnostic Market report?

Ans: The Applications covered in the Companion Diagnostic Market report are Oncology, Cardiovascular, Central Nervous System, Virology, Others

What are the Type segmentation covered in the Companion Diagnostic Market report?

Ans: The Types covered in the Companion Diagnostic Market report are Immunohistochemistry, Molecular Diagnosis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immunohistochemistry

1.2.3 Molecular Diagnosis

1.3 Market by Application

1.3.1 Global Companion Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous System

1.3.5 Virology

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Companion Diagnostic Market Perspective (2020-2031)

2.2 Global Companion Diagnostic Growth Trends by Region

2.2.1 Global Companion Diagnostic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Companion Diagnostic Historic Market Size by Region (2020-2025)

2.2.3 Companion Diagnostic Forecasted Market Size by Region (2026-2031)

2.3 Companion Diagnostic Market Dynamics

2.3.1 Companion Diagnostic Industry Trends

2.3.2 Companion Diagnostic Market Drivers

2.3.3 Companion Diagnostic Market Challenges

2.3.4 Companion Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Companion Diagnostic Players by Revenue

3.1.1 Global Top Companion Diagnostic Players by Revenue (2020-2025)

3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2020-2025)

3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Companion Diagnostic Revenue

3.4 Global Companion Diagnostic Market Concentration Ratio

3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2024

3.5 Global Key Players of Companion Diagnostic Head office and Area Served

3.6 Global Key Players of Companion Diagnostic, Product and Application

3.7 Global Key Players of Companion Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Breakdown Data by Type

4.1 Global Companion Diagnostic Historic Market Size by Type (2020-2025)

4.2 Global Companion Diagnostic Forecasted Market Size by Type (2026-2031)

5 Companion Diagnostic Breakdown Data by Application

5.1 Global Companion Diagnostic Historic Market Size by Application (2020-2025)

5.2 Global Companion Diagnostic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Companion Diagnostic Market Size (2020-2031)

6.2 North America Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Companion Diagnostic Market Size by Country (2020-2025)

6.4 North America Companion Diagnostic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Companion Diagnostic Market Size (2020-2031)

7.2 Europe Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Companion Diagnostic Market Size by Country (2020-2025)

7.4 Europe Companion Diagnostic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Companion Diagnostic Market Size (2020-2031)

8.2 Asia-Pacific Companion Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Companion Diagnostic Market Size by Region (2020-2025)

8.4 Asia-Pacific Companion Diagnostic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Companion Diagnostic Market Size (2020-2031)

9.2 Latin America Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Companion Diagnostic Market Size by Country (2020-2025)

9.4 Latin America Companion Diagnostic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Companion Diagnostic Market Size (2020-2031)

10.2 Middle East & Africa Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Companion Diagnostic Market Size by Country (2020-2025)

10.4 Middle East & Africa Companion Diagnostic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Holdings

11.1.1 Roche Holdings Company Details

11.1.2 Roche Holdings Business Overview

11.1.3 Roche Holdings Companion Diagnostic Introduction

11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2020-2025)

11.1.5 Roche Holdings Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Companion Diagnostic Introduction

11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction

11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Details

11.4.2 Agilent Technologies Business Overview

11.4.3 Agilent Technologies Companion Diagnostic Introduction

11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2020-2025)

11.4.5 Agilent Technologies Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Companion Diagnostic Introduction

11.5.4 Merck Revenue in Companion Diagnostic Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Agendia

11.6.1 Agendia Company Details

11.6.2 Agendia Business Overview

11.6.3 Agendia Companion Diagnostic Introduction

11.6.4 Agendia Revenue in Companion Diagnostic Business (2020-2025)

11.6.5 Agendia Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Companion Diagnostic Introduction

11.7.4 Qiagen Revenue in Companion Diagnostic Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Companion Diagnostic Introduction

11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2020-2025)

11.8.5 Myriad Genetics Recent Development

11.9 Advanced Cell Diagnostics

11.9.1 Advanced Cell Diagnostics Company Details

11.9.2 Advanced Cell Diagnostics Business Overview

11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction

11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2020-2025)

11.9.5 Advanced Cell Diagnostics Recent Development

11.10 Danaher

11.10.1 Danaher Company Details

11.10.2 Danaher Business Overview

11.10.3 Danaher Companion Diagnostic Introduction

11.10.4 Danaher Revenue in Companion Diagnostic Business (2020-2025)

11.10.5 Danaher Recent Development

11.11 Illumina, Inc

11.11.1 Illumina, Inc Company Details

11.11.2 Illumina, Inc Business Overview

11.11.3 Illumina, Inc Companion Diagnostic Introduction

11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2020-2025)

11.11.5 Illumina, Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Roche Holdings

Merck

Agendia

Advanced Cell Diagnostics

List of Tables

Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immunohistochemistry

Table 3. Key Players of Molecular Diagnosis

Table 4. Global Companion Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Companion Diagnostic Market Share by Region (2020-2025)

Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Companion Diagnostic Market Share by Region (2026-2031)

Table 10. Companion Diagnostic Market Trends

Table 11. Companion Diagnostic Market Drivers

Table 12. Companion Diagnostic Market Challenges

Table 13. Companion Diagnostic Market Restraints

Table 14. Global Companion Diagnostic Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Companion Diagnostic Market Share by Players (2020-2025)

Table 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2024)

Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Companion Diagnostic, Headquarters and Area Served

Table 20. Global Key Players of Companion Diagnostic, Product and Application

Table 21. Global Key Players of Companion Diagnostic, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Companion Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Companion Diagnostic Revenue Market Share by Type (2020-2025)

Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Companion Diagnostic Revenue Market Share by Type (2026-2031)

Table 27. Global Companion Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Companion Diagnostic Revenue Market Share by Application (2020-2025)

Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Companion Diagnostic Revenue Market Share by Application (2026-2031)

Table 31. North America Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Companion Diagnostic Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Holdings Company Details

Table 47. Roche Holdings Business Overview

Table 48. Roche Holdings Companion Diagnostic Product

Table 49. Roche Holdings Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 50. Roche Holdings Recent Development

Table 51. Abbott Laboratories Company Details

Table 52. Abbott Laboratories Business Overview

Table 53. Abbott Laboratories Companion Diagnostic Product

Table 54. Abbott Laboratories Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 55. Abbott Laboratories Recent Development

Table 56. Thermo Fisher Scientific Company Details

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific Companion Diagnostic Product

Table 59. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. Agilent Technologies Company Details

Table 62. Agilent Technologies Business Overview

Table 63. Agilent Technologies Companion Diagnostic Product

Table 64. Agilent Technologies Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 65. Agilent Technologies Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Companion Diagnostic Product

Table 69. Merck Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Agendia Company Details

Table 72. Agendia Business Overview

Table 73. Agendia Companion Diagnostic Product

Table 74. Agendia Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 75. Agendia Recent Development

Table 76. Qiagen Company Details

Table 77. Qiagen Business Overview

Table 78. Qiagen Companion Diagnostic Product

Table 79. Qiagen Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Myriad Genetics Company Details

Table 82. Myriad Genetics Business Overview

Table 83. Myriad Genetics Companion Diagnostic Product

Table 84. Myriad Genetics Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 85. Myriad Genetics Recent Development

Table 86. Advanced Cell Diagnostics Company Details

Table 87. Advanced Cell Diagnostics Business Overview

Table 88. Advanced Cell Diagnostics Companion Diagnostic Product

Table 89. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 90. Advanced Cell Diagnostics Recent Development

Table 91. Danaher Company Details

Table 92. Danaher Business Overview

Table 93. Danaher Companion Diagnostic Product

Table 94. Danaher Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 95. Danaher Recent Development

Table 96. Illumina, Inc Company Details

Table 97. Illumina, Inc Business Overview

Table 98. Illumina, Inc Companion Diagnostic Product

Table 99. Illumina, Inc Revenue in Companion Diagnostic Business (2020-2025) & (US$ Million)

Table 100. Illumina, Inc Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Companion Diagnostic Picture

Figure 2. Global Companion Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Companion Diagnostic Market Share by Type: 2024 VS 2031

Figure 4. Immunohistochemistry Features

Figure 5. Molecular Diagnosis Features

Figure 6. Global Companion Diagnostic Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Companion Diagnostic Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Cardiovascular Case Studies

Figure 10. Central Nervous System Case Studies

Figure 11. Virology Case Studies

Figure 12. Others Case Studies

Figure 13. Companion Diagnostic Report Years Considered

Figure 14. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Companion Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Companion Diagnostic Market Share by Region: 2024 VS 2031

Figure 17. Global Companion Diagnostic Market Share by Players in 2024

Figure 18. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2024

Figure 20. North America Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Companion Diagnostic Market Share by Country (2020-2031)

Figure 22. United States Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Companion Diagnostic Market Share by Country (2020-2031)

Figure 26. Germany Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Companion Diagnostic Market Share by Region (2020-2031)

Figure 34. China Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Companion Diagnostic Market Share by Country (2020-2031)

Figure 42. Mexico Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Companion Diagnostic Market Share by Country (2020-2031)

Figure 46. Turkey Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 50. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 52. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 54. Agendia Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 55. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 56. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 57. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 58. Danaher Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 59. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions